Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
I'm PortAI, I can summarize articles.
Shares of Inovio Pharmaceuticals Inc. (INO) fell 6.80% to $1.92 on Monday, underperforming compared to competitors. The NASDAQ Composite Index fell 0.38% and the Dow Jones Industrial Average fell 0.90%. Inovio's stock is 58.35% below its 52-week high. Competitors Johnson & Johnson fell 0.76%, Statera Biopharma remained unchanged, and Pfizer fell 1.83%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments